Antidote Treatment Nerve Agent Auto-Injector Tender in USA - 83996514

Procurement Summary

Country: USA

Summary: Antidote Treatment Nerve Agent Auto-Injector (Atnaa)

Deadline: 05 Jul 2023

Posting Date: 07 Jun 2023

Other Information

Notice Type: Tender

TOT Ref.No.: 83996514

Document Ref. No.: SPE2DP-23-R-0002

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Description
The Defense Logistics Agency Troop Support is seeking sources capable of providing the Antidote Treatment Nerve Agent Auto-Injector (ATNAA). DLA Troop Support is contemplating awarding a one-year base and two one-year option, indefinite quantity contract for ATNAA. The quantities to be ordered are estimated at 225, 000 units minimum and 1, 000, 000 units maximum per contract year. However, the quantity may increase or decrease as the Services requirements change.
The ATNAA shall be licensed by the Food and Drug Administration (FDA). Each auto-injector shall deliver 2.1 mg of atropine and 600mg of pralidoxime chloride in separate chambers, and be suitable for intramuscular administration.
Must have FDA approval to sell the ATNAA before award of the contract.
If your firm currently manufactures or distributes the ATNAA, please provide information with respect to the following:
a) Place of manufactureb) Estimated annual capacityc) FDA registrationd) Product name and description including description of any special featurese) Current unit sale pricef) Estimated inventory level and storage requirements
*** NEW PRODUCTS UNDER DEVELOPMENT***
For products under development, describe the current stage of development and whether the product has undergone independent laboratory testing or FDA testing/trials etc. Firms and organizations that currently develop or manufacture the ATNAA or that have technologies, pharmaceuticals, or manufacturing capabilities under development are invited to submit information to DLA Troop Support.
Data obtained from this Request For Information (RFI) will be used by DLA Troop Support in making recommendations and decisions on the development of an appropriate planning and procurement strategy for the ATNAA. All information submitted shall remain with the U.S. Government and will not be returned. It will be kept confidential as allowed by relevant Federal law and will be eligible for a...
Active Contract Opportunity

Notice ID : SPE2DP-23-R-0002

Related Notice

Department/Ind. Agency : DEPT OF DEFENSE

Sub-tier : DEFENSE LOGISTICS AGENCY (DLA)

Major Command : TROOP SUPPORT MEDICAL

Office : DLA TROOP SUPPORT

General Information

Contract Opportunity Type: Sources Sought (Original)

All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA

Original Published Date: Jun 06, 2023 03:21 pm EDT

Original Response Date:

Inactive Policy: Manual

Original Inactive Date: Jul 05, 2023

Initiative: None
Classification

Original Set Aside:

Product Service Code:

NAICS Code:

Place of Performance:

Documents

 Tender Notice